Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Brzozow – page 4

41 clinical trials in Brzozow, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Brzozow at a glance
41
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

41 trials in Brzozow

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Aprepitant
  • Sponsor:Karyopharm Therapeutics Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sunitinib
  • Sponsor:Cogent Biosciences Inc.

Renal cell carcinoma

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merck Sharp & Dohme LLC
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Aveo Pharmaceuticals Inc.

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Brzozow

What the registry says about research in the country

01 Hematologic Malignancies

Groundbreaking clinical trials focusing on multiple myeloma, leukemia, and lymphoma treatments. Studies evaluate novel combination therapies and targeted approaches for both newly diagnosed and relapsed/refractory patients.

  • Multiple Myeloma Treatment Innovations
  • Chronic Lymphocytic Leukemia Research
  • Mantle Cell Lymphoma Therapies

Research includes evaluation of monoclonal antibodies, targeted therapies, and immunotherapy combinations.

02 Gastrointestinal Oncology

Studies examining advanced treatments for gastric cancer and colorectal cancer, with particular focus on targeted therapies for specific genetic mutations and biomarker-driven approaches.

  • BRAF-Mutant Colorectal Cancer
  • Gastroesophageal Junction Cancer
  • Novel Combination Therapies

Trials incorporate innovative treatment combinations including immunotherapy and targeted agents.

03 Advanced Therapeutics

Cutting-edge research evaluating personalized treatment strategies across various cancer types, including studies of novel drug combinations and targeted approaches for rare conditions.

  • Myeloproliferative Disorders
  • Breast Cancer Innovations
  • Renal Cell Carcinoma Treatment

Focus on precision medicine approaches and biomarker-driven treatment selection.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.